Significant impacts of CYP3A4*1G and CYP3A5*3 genetic polymorphisms on the pharmacokinetics of diltiazem and its main metabolites in Chinese adult kidney transplant patients.

Significant impacts of CYP3A41G and CYP3A53 genetic polymorphisms on the pharmacokinetics of diltiazem and its main metabolites in Chinese adult kidney transplant patients.

Item

http://www.wikidata.org/entity/Q54435691

Q54435691

about

Significant impacts of CYP3A41G and CYP3A53 genetic polymorphisms on the pharmacokinetics of diltiazem and its main metabolites in Chinese adult kidney transplant patients.

Item

http://www.wikidata.org/entity/Q54435691

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Significant impacts of CYP3A4* ...... lt kidney transplant patients.

@en

Significant impacts of CYP3A4* ...... lt kidney transplant patients.

@nl

type

Item

label

Significant impacts of CYP3A4* ...... lt kidney transplant patients.

@en

Significant impacts of CYP3A4* ...... lt kidney transplant patients.

@nl

prefLabel

Significant impacts of CYP3A4* ...... lt kidney transplant patients.

@en

Significant impacts of CYP3A4* ...... lt kidney transplant patients.

@nl

P1476

Significant impacts of CYP3A4* ...... lt kidney transplant patients.

@en

P2093

H Yuan

http://www.w3.org/2001/XMLSchema#string

J-L Wang

http://www.w3.org/2001/XMLSchema#string

K Chen

http://www.w3.org/2001/XMLSchema#string

L-J Zhu

http://www.w3.org/2001/XMLSchema#string

L-Y Zhou

http://www.w3.org/2001/XMLSchema#string

Q-J Chen

http://www.w3.org/2001/XMLSchema#string

X-C Zuo

http://www.w3.org/2001/XMLSchema#string

Y Ma

http://www.w3.org/2001/XMLSchema#string

Y-N Zhou

http://www.w3.org/2001/XMLSchema#string

Y-X Peng

http://www.w3.org/2001/XMLSchema#string

P2860

CYP3A4 and CYP3A5 genotyping by Pyrosequencing

Genetic polymorphisms in MDR1, CYP3A4 and CYP3A5 genes in a Ghanaian population: a plausible explanation for altered metabolism of ivermectin in humans?

CYP3A variation and the evolution of salt-sensitivity variants

The human genome project and novel aspects of cytochrome P450 research.

The effects of diltiazem in renal transplantation patients treated with cyclosporine A

Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects.

CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activity.

CYP3A4*1G genetic polymorphism influences CYP3A activity and response to fentanyl in Chinese gynecologic patients.

Identification of functionally variant MDR1 alleles among European Americans and African Americans.

Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism.

P304

341-347

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JCPT.12394

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27149910

http://www.w3.org/2001/XMLSchema#string

Significant impacts of CYP3A4*1G and CYP3A5*3 genetic polymorphisms on the pharmacokinetics of diltiazem and its main metabolites in Chinese adult kidney transplant patients.

about

Significant impacts of CYP3A4*1G and CYP3A5*3 genetic polymorphisms on the pharmacokinetics of diltiazem and its main metabolites in Chinese adult kidney transplant patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

Significant impacts of CYP3A41G and CYP3A53 genetic polymorphisms on the pharmacokinetics of diltiazem and its main metabolites in Chinese adult kidney transplant patients.

Significant impacts of CYP3A41G and CYP3A53 genetic polymorphisms on the pharmacokinetics of diltiazem and its main metabolites in Chinese adult kidney transplant patients.